Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Idioma
Intervalo de año de publicación
1.
Klin Lab Diagn ; 60(1): 60-3, 2015 Jan.
Artículo en Ruso | MEDLINE | ID: mdl-25874308

RESUMEN

The modern laboratory medicine provides observation of requirements to glucometers in line with standard DIN EN ISO 15197-2:2013 for self-control under treatment of patients with diabetes mellitus and registration of biologic types data. The study compared functioning of diagnostic devices in point-of-care of four manufacturers. The samples of whole blood taken from two patients were analyzed in three lots of test-strips with concentration of glucose 4.5 and 11.8 mmol/l using glucometers Accu-Chek Active, One Touch Select, Sattelite Express and Contour TS and reference analyzer Olympus AU 400. The results of measurements were analyzed using technique of separated test of patient. The results demonstrated that precision indicators of measurement of blood glucose on glucometers Accu-Chek Active and One Touch Select were within the scope of quality criteria DIN EN ISO 15197-2:2013. The results of testing of glucometer Sattelite Express exceeded the given criteria under measurement of normoglycemic level of concentration and for Contour TS in all range of measured values.


Asunto(s)
Automonitorización de la Glucosa Sanguínea/instrumentación , Automonitorización de la Glucosa Sanguínea/normas , Glucemia , Diabetes Mellitus/sangre , Diabetes Mellitus/patología , Glucosa/metabolismo , Humanos , Valores de Referencia
2.
Vestn Khir Im I I Grek ; 162(6): 51-6, 2003.
Artículo en Ruso | MEDLINE | ID: mdl-14997816

RESUMEN

The observation included 40 patients (20 men and 20 women) with the rheumatic heart diseases acquired at the age of (45.9 +/- 8.7) years after isolated prostheses of the aortal (n = 25) and mitral (n = 15) valves with bicuspid constructions of AHV "MedInzh-2" in remote terms in (2.52 +/- 0.48) years, I-II functional valve (NYHA). It was shown that only a permanent control not rarer than once a month and an adequate correction by means of anticoagulation and antiaggregation therapy using standard methods for patients with the bicuspid AHV made it possible to avoid the development of thromboses and thromboembolic complications during three years of observation.


Asunto(s)
Estenosis de la Válvula Mitral/terapia , Marcapaso Artificial , Tromboembolia/terapia , Trombosis/terapia , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Estenosis de la Válvula Mitral/prevención & control , Tromboembolia/prevención & control , Trombosis/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA